This article provides an overview of prosthetic valve-related endocarditis, highlighting its rising incidence, high mortality, diagnostic challenges, and management strategies.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to prosthetic valve endocarditis burden; leaves open optimal prevention and diagnostic strategies.
In Brief Overview: The incidence of infective endocarditis, an inflammation of the heart valves, the endocardium, or both that’s caused by bacterial, viral, or fungal agents, continues to rise despite advances in treatment. People with prosthetic valves are among those at highest risk, and mortality rates can be extremely high, especially in cases of early onset. Diagnosis is challenging, in part because signs and symptoms associated with systemic infections can mask signs of the underlying endocarditis. This article outlines the causes and effects of prosthetic valve–related endocarditis (PVE), describes its signs and symptoms, discusses the leading diagnostic tests and criteria, and addresses prevention and treatment, as well as nursing implications. Although endocarditis is relatively rare—an estimated 15,000 to 20,000 new cases are diagnosed annually—people with prosthetic valves are among those at highest risk.
No takes yet. Share an insight, caveat, or question.
Anne Fink (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: